An ultra-powerful MRI device that reduces examination time from 30 minutes to 30 seconds, a waterjet surgical robot that eliminates thermal injury risks, and an international medical service platform delivering end-to-end services, these innovative medical devices and servicesincluding bilingual consultations, cross-border diagnoses, and commercial insurance settlements, which were put on display at the 2024 CIFTIS, have now been put into practice.
A special event for the Health Services section of the 2024 CIFTIS interview series titled "Growing Together with CIFTIS" was successfully held at the China National Convention Center on March 20, 2025. The event was co-hosted by Beijing International Trade in Services Center and Beijing Capital Group Exhibitions & Events. Representatives from a multitude of enterprises and institutions, including Johnson & Johnson China, United Imaging, Amcare, Healinno Tech, and Guang'anmen Hospital, engaged in face-to-face discussions with media outlets, sharing their experience and achievements from showcasing their innovative medical products and solutions at the 2024 CIFTIS, while outlining their visions for the 2025 session. Wu Jinmei, deputy director-general of Beijing International Trade in Services Center, chaired the event.
Liu Yunxue, general manager of the CIFTIS Center at Beijing Capital Group Exhibitions & Events Co., Ltd., provided updates on preparations for the Health Services section of the 2025 CIFTIS, highlighting five key measures: first, enhancing the multi-agency coordination mechanism involving five government departments, four biopharmaceutical industrial parks, and academic organizations to consolidate preparatory efforts; second, curating a healthcare plus AI interactive zone during the exhibition, alongside launch ceremonies, hospital-enterprise salons, and science popularization lectures; third, hosting high-level conferences, including the Beijing Capital International Medical Conference and parallel forums; fourth, highlighting scientific and technological innovation by attracting leading medical and pharmaceutical enterprises (e.g., Fortune Global 500 companies) and high-tech SMEs; fifth, leveraging integrated media to showcase distinctive features of the section in public-friendly formats before, during, and after the event, to boost social engagement and impact.
Zhao Jun, vice president of Government Affairs, Johnson & Johnson China, shared via video link the company's achievements from participating in the 2024 CIFTIS. He noted that Johnson & Johnson is a regular participant in CIFTIS. Last year, its MedTech division showcased dozens of innovations, earning significant attention and acclaim. Notably, one of the exhibits, the MONARCH®, China's first regulatory-approved robotic platform for natural orifice transluminal endoscopic surgery, is now widely used in clinics. "China is a key strategic market for Johnson & Johnson. We are optimistic about the growth potential of its healthcare sector and will continue to collaborate with government and industry partners to deliver innovative medical products and solutions that improve the health and well-being of Chinese patients," he stated.
Lv Cinian, general manager of Beijing Business, United Imaging, said that the CIFTIS, as an international event dedicated to trade in services, provides an important platform to showcase the latest products and technologies. At the 2024 CIFTIS, the company debuted a number of diagnosis and treatment devices, including the world's first whole-body UHF 5.0T MR, the world's first Total-Body PET/CT system, and the full range of uOrigin microelectronic hearing aids. These launches demonstrated the cutting-edge capabilities of China's indigenous high-end medical devices. "Participation in CIFTIS has significantly boosted United Imaging's brand visibility and industry influence while attracting the attention and support of government authorities, global partners and media representatives. Moving forward, we will harness this platform to make substantive contributions to Beijing's healthcare cause," he added.
Zhu Zhiling, marketing director of Amcare Healthcare Group, stated that participating in the 2024 CIFTIS marked a milestone for the group. The CIFTIS not only allowed us to showcase innovation capabilities and expand global partnerships, but also highlighted China's determination to promote institutional opening-up in healthcare. This reinforces our confidence to accelerate global expansion while delivering high-quality services, said Zhu. Looking ahead to 2025, Amcare, as a representative private healthcare provider, will leverage the CIFTIS to systematically showcase more of its achievements and innovative projects in practicing the Healthy China Initiative, including the latest progress in international medical services, technological innovation, and smart hospital management. Through special forums and interactive exhibitions, the company looks forward to in-depth exchanges and cooperation with more global peers, to jointly advance the high-quality development of the healthcare sector.
Luo Jueyong, director of Public Affairs, Beijing Healinno Medical Technology Co., Ltd. (Healinno Tech), highlighted that the company made a remarkable debut at the 2024 CIFTIS, capturing the spotlight with its groundbreaking innovations - metaFlow®, China's first waterjet surgical robot, earning widespread recognition and valuable opportunities. Moving forward, Healinno Tech remains committed to making advanced healthcare universally accessible through independent innovation, living up to its corporate vision of "Innovating for a Healthier Future". It is dedicated to developing world-class medical devices by combining cutting-edge technology with practical solutions. The company will maintain an active presence at the 2025 CIFTIS and beyond. Leveraging this platform, it will showcase China's medical innovations to domestic and international visitors, supporting the Healthy China Initiative while delivering high-quality healthcare solutions worldwide to enhance global health.
Liu Xinyan, director of International Medical Department, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, said that in 2024 the hospital used the CIFTIS as a fulcrum to establish an international medical services platform, delivering end-to-end services for patients around the world, including Chinese-English bilingual consultations, cross-border diagnoses, and commercial insurance settlements. The launch of this platform represents a paradigm shift in TCM globalization, transitioning from isolated collaborations to integrated service provision. Furthermore, the application of digital tools like the bilingual TCM electronic medical record system, AI-powered guidance robot, and TCM health mall has facilitated the transition of TCM services trade from conventional offline operations to hybrid O2O (online-to-offline) service delivery. Going forward, Guang'anmen Hospital will continue to utilize the CIFTIS platform to expand TCM partnerships along the Belt and Road; accelerate digital transformation in TCM; build a system for TCM service trade standards; and pioneer integrated models combining TCM with tourism and elderly care to cultivate new forms of TCM services trade.
● China International Fair for Trade in Services (CIFTIS) is co-hosted by the Ministry of Commerce of the People’s Republic of China and the People’s Government of Beijing Municipality.
● CIFTIS is the largest comprehensive fair in the field of global trade in services, serving as an exhibition window, communication platform and cooperation bridge for the service industry and trade in services.
Scan the QR code to follow the subscription account of CIFTIS.
Scan the QR code to follow the service account of CIFTIS.